About Clade TX
Clade TX is a company based in Cambridge (United States) founded in 2020 by Leandro Vetcher was acquired by Century Therapeutics in April 2024. Clade TX has raised $87 million across 1 funding round from investors including Century Therapeutics, Syncona and Bristol-Myers Squibb. The company has 13 employees as of December 31, 2021. Clade TX has completed 1 acquisition, including Gadeta. Clade TX operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Cambridge, United States
- Employees 13 as on 31 Dec, 2021
- Founders Leandro Vetcher
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Clade Therapeutics, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$87 M (USD)
in 1 rounds
-
Latest Funding Round
$87 M (USD), Series A
Nov 03, 2021
-
Investors
Century Therapeutics
& 4 more
-
Employee Count
13
as on Dec 31, 2021
- Investments & Acquisitions
-
Acquired by
Century Therapeutics
(Apr 12, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Clade TX
Unlock access to complete
Funding Insights of Clade TX
Clade TX has successfully raised a total of $87M through 1 strategic funding round. The most recent funding activity was a Series A round of $87 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Clade TX
Clade TX has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Century Therapeutics, Syncona and Bristol-Myers Squibb.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investments are managed via private equity by Syncona.
|
Locked | Locked | Locked | |
|
Healthcare startups are funded by this corporate-backed venture capital entity.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Clade TX
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Clade TX
Clade TX has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Gadeta.
Investment portfolio details for Clade TX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
T Cell based cancer therapies based on gamma delta (γδ) T cell receptors
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for Clade TX
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Clade TX
Detailed financials for Clade TX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Clade Tx Comparisons
Peer comparison for Clade TX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Clade TX
Clade TX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
Detailed competitors of Clade TX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Clade Tx
Complete news archive for Clade TX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clade TX
Clade TX was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Clade TX is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Clade TX is a funded company, having raised a total of $87M across 1 funding round to date.
As of Dec 31, 2021, the latest employee count at Clade TX is 13.
Clade was founded in 2020 and is based in Cambridge, United States. Platform technologies are utilized by the company to create therapies derived from human pluripotent stem cells and their derivatives. These therapies focus on cell transplantation for cancer treatment within the biotechnology sector. Operations emphasize the advancement of stem cell-based solutions for oncology applications.
Clade TX's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Clade TX has made 1 acquisition, including Gadeta.
Clade TX has 5 investors. Key investors include Century Therapeutics, Syncona, Bristol-Myers Squibb, LifeSci Venture Partners, and Emerson Collective.